Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF

Bone Marrow Transplantation
G PrattG M Smith

Abstract

Autologous transplantation in CML has been a focus of interest over the last few years. Determining the indications, optimal timing and method for this procedure remains controversial. One approach has been the mobilisation of Philadelphia chromosome negative (Ph-) peripheral blood stem cells following high-dose chemotherapy as a method of purging the graft. We have described a mobilisation regimen of 7 days of hydroxyurea followed by G-CSF and have shown it to be substantially less toxic than other methods. We now report further experience with this technique in a total of 18 patients and the outcome of transplantation in seven patients using cells so-derived. Following mobilisation, approximately a third of patients had 100% Ph-collections and half had less than 50% Ph+ collections. All patients were 100% Ph+ prior to mobilisation. Six out of seven transplanted patients showed sustained engraftment and two of these patients became 18 and 34% Ph+ 3 months post-transplant. Five patients remain alive and well 13 to 25 months post-autograft. In conclusion, we have developed a well-tolerated regimen for Ph- PBSC mobilisation and have demonstrated that such cells are capable of sustained engraftment and of producing significant cyt...Continue Reading

Citations

Jul 10, 1999·Current Opinion in Hematology·U R Osarogiagbon, P B McGlave
Jul 24, 2004·Hematology/oncology Clinics of North America·Ravi Bhatia, Philip B McGlave
Dec 22, 2000·Blood Reviews·S Fu, J Liesveld
Jun 23, 2004·Journal of Applied Physiology·Tina J PatelRichard L Lieber
Aug 30, 2003·Oncogene·Paul DentSteven Grant
Oct 19, 2001·Oncogene·P L Bergsagel, W M Kuehl
Dec 29, 2007·American Journal of Physiology. Lung Cellular and Molecular Physiology·Joseph P Mizgerd, Shawn J Skerrett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.